the EBIT 6.5m is again only a forecast (they have a track record...

First 189 Last

Share
Profile

Follow
Warnie

17,232 Posts.

954

23/12/19

08:07

Post #: 42096091
Share
Originally posted by HCuser3: ↑

Let me get this right;

ISX have essentially been Tier 1 operational for only 10.5 months.
Forecast EBIT of $6.5M and despite the downgrade is in an unusual position for a young technology stock who always burn cash.
Has a monthly EBIT forecast of $2M with a reasonable chance of delivering a maiden profit - year 1 of effective operations.
Are cash flow positive.
$14.5m cash in the bank, a ~12% increase from the June 30 position.
Debt free and in a capital positive position to self fund growth.
$80m in clients funds, a 235% increase from the June 30 position.
Every merchant acquiring and GPTV metric is moving in the right direction +325% and +425% respectively.
Will stand up its own SWIFT backbone, reduce risk of exposure to AU banks broken regulatory infrastructure and improve margin.
Are at the Technology and Service Offering right time and place with regard to increasing regulatory oversight in EU, AU and the US.
Technical staff footprint is increasing.

.... and that equates to this thing being cooked?

You better get across to APT, WTC, Z1P threads and any of the other no profit forecast, major cash burn stocks and spread the good word!

Expand

the EBIT 6.5m is again only a forecast (they have a track record already of under achieving) and doesn't include one off cash items (so its BS) as usual

ISX have always known when they started as Tier 1 yet never downgraded until December (more BS) from above

monthly EBIT of $2m ???? Where? Oh not another made up number?

Cash Flow positive? Really how so?
ISX Price at posting: $1.07 Sentiment: Sell Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

BRX

Belararox delineates another porphyry in Argentina at Tambo South

EMD

Emyria's Empax Centre chosen for mental health clinical trial

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

STX

Strike Energy secures $153 million for Perth Basin gas projects

FHE

Frontier Energy achieves key milestone for Waroona energy project

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing